[Ipratropium bromide in COPD. Cost effectiveness of the treatment of COPD with ipratropium bromide].
Puig
X
X
D001993:Bronchodilator Agents / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D006801:Humans; D009241:Ipratropium / Q000191:economics / Q000627:therapeutic use*; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000191:economics; D008875:Middle Aged
D001993:Bronchodilator Agents; D009241:Ipratropium